Veterinaria
Fakultatea
Hospital de la Santa Creu i Sant Pau
Barcelona, EspañaHospital de la Santa Creu i Sant Pau-ko ikertzaileekin lankidetzan egindako argitalpenak (17)
2023
-
Spanish Antibiogram Committee (COESANT) recommendations for cumulative antibiogram reports
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 7, pp. 430-435
2022
-
CD69 expression on regulatory T cells protects from immune damage after myocardial infarction
The Journal of clinical investigation, Vol. 132, Núm. 21
2021
-
Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review
Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 245-257
2020
-
Deletion or Inhibition of NOD1 Favors Plaque Stability and Attenuates Atherothrombosis in Advanced Atherogenesis †
Cells, Vol. 9, Núm. 9
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187
-
The evolving microbiome from pregnancy to early infancy: A comprehensive review
Nutrients, Vol. 12, Núm. 1
2019
-
CIBER-CLAP (CIBERCV Cardioprotection Large Animal Platform): A multicenter preclinical network for testing reproducibility in cardiovascular interventions
Scientific Reports, Vol. 9, Núm. 1
-
Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1
FASEB Journal, Vol. 33, Núm. 3, pp. 3912-3921
-
Rationale and Study Design for an Individualized Perioperative Open Lung Ventilatory Strategy in Patients on One-Lung Ventilation (iPROVE-OLV)
Journal of Cardiothoracic and Vascular Anesthesia, Vol. 33, Núm. 9, pp. 2492-2502
2018
-
MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis
Nature Communications, Vol. 9, Núm. 1
2017
-
Rationale and study design for an individualised perioperative open-lung ventilatory strategy with a high versus conventional inspiratory oxygen fraction (iPROVE-O2) and its effects on surgical site infection: Study protocol for a randomised controlled trial
BMJ Open, Vol. 7, Núm. 7
-
Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)
Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253
2015
-
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
-
Rationale and study design for an individualized perioperative open lung ventilatory strategy (iPROVE): Study protocol for a randomized controlled trial
Trials, Vol. 16, Núm. 1
2007
-
Evolution of the antimicrobial resistance of Pseudomonas aeruginosa in Spain: Second National Study (2003)
Revista Espanola de Quimioterapia, Vol. 20, Núm. 2, pp. 222-229
1996
-
Informe sobre resistencia microbiana: ¿qué hacer?
Medicina Clinica